-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

Benzinga·09/08/2026 14:54:50
语音播报
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.